Navigation Links
Dabur Research to set up Drug Discovery Center in Oman

>
The new center is expected to have special ships with laboratories on board for study of marine species.

If taken seriously, Mukherjee feels, marine resources could offer a lot of nutraceuticals or food supplements and nutrients that can help cure a number of ailments like cancer.

The global nutraceutical market currently has several major players like Wockhardt, Lupin, Morepen Laboratories, Dabur and Himalaya competing in a market pegged at around $74 billion.

"We are looking for investments in Oman partly as we want early discovery done there. We also want to do the process and manufacturing there for marketing the product across the world. We also want to develop a marine depository in Oman," said Mukherjee.

The project envisages research and development of both nutraceuticals and therapeutic drugs. All these activities are expected to generate a market for trained manpower within Oman and also open up avenues for entrepreneurs.

Mukherjee sees potential to develop anti-cancer, anti-aging, anti-obesity and other such drugs that could help improve the quality of life.

Within the country also DRF is networking with over a score of universities and institutions to develop products and drugs that could provide cures or improve health of human beings.

Source-IANS
'"/>




Page: 1 2

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...vors of the 2003 epidemic severe acute respiratory...fered lingering mental health problems, according ...tory syndrome (SARS) became a global epidemic in 2...he largest concentration of North American cases o...
...he almost 40 million men, women and children livin...n, the United Nations agency dealing with AIDS tod... confidentiality is not compromised in the process...on on the virus. UNAIDS Senior Technical Officer E...
...d in TN for allowing 15-year-old to perform caesar...Nadu on Monday arrested the doctor parents of a 15...n on a woman sometime ago.Key words: caesarean sec... hurt, endangering, life, safety, cheating, clinic...
...rses who are seeking pay rises remained camped out...rned they would stay put for weeks unless the gove...mp on a grass verge opposite the government headqu...he wake of a demonstration by 4,500 medical worker...
Other Medicine News:Health News:SARS Patients Experience Mental Health Decline 2Health News:Patient Confidentiality Must Be Ensured-UNAIDS 2Health News:Patient Confidentiality Must Be Ensured-UNAIDS 3Health News:The Doctor Parents of a 15 Year Old surgeon Arrested 2Health News:Street-protesting Polish Nurses Threaten to Stay Put 2
(Date:10/10/2008)... WASHINGTON and MENLO PARK, Calif., Oct. 10 /...T ) today announced that it plans to present,long-...clinical trials next,week at the Cardiovascular Re...theter Cardiovascular Therapeutics (TCT) meeting i...rospective studies designed to investigate,the saf...
(Date:10/10/2008)... WALTHAM, Mass., Oct. 10 /PRNewswire-FirstCal...IMA ), a leading provider of near-patient,diagnost...et yesterday with,Ban Ki-moon, the Secretary-Gener...nior executives of seventeen of the world,s leadin...agnostic companies.,Inverness, together with senio...
(Date:10/9/2008)... North American Campaign to Spread Awareness ...ASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- 133 m...tal care due to causes such as natural,disaster, c... (SOS-USA) is,observing World Orphan Week by calli...To view the Multimedia News Release, go to:, htt...
(Date:10/9/2008)... Top Line Clinical Results Expected in Novemb...Call/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announce...osing,for the third of its three pivotal trials to...on of 12-hour extended-release (ER) ibuprofen for,...ects to report top-line,results from this pivotal ...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Glaucoma Treatment 3Ci 3ECan 3C i 3E Prevent Blindness 23147 1Glaucoma Treatment 3Ci 3ECan 3C i 3E Prevent Blindness 23147 2Glaucoma Treatment 3Ci 3ECan 3C i 3E Prevent Blindness 23147 3Synthetic molecules emulate enzyme behavior for the first time 3871 1Synthetic molecules emulate enzyme behavior for the first time 3871 2Synthetic molecules emulate enzyme behavior for the first time 3871 3Allscripts to Announce Second Quarter 2008 Results on August 5th 23143 1Allscripts to Announce Second Quarter 2008 Results on August 5th 23143 2Allscripts to Announce Second Quarter 2008 Results on August 5th 23143 3AIDS Walk San Francisco Boosts Number of Teams and Benefiting Agencies 23139 1AIDS Walk San Francisco Boosts Number of Teams and Benefiting Agencies 23139 2AIDS Walk San Francisco Boosts Number of Teams and Benefiting Agencies 23139 3
...nal Myeloma Workshop held in,Kos, Greece demonstra... with bortezomib, dexamethasone and lenalidomide p...ctory multiple,myeloma, and as a single agent in p...roglobulinemia, NEW YORK, June 29, 2007 /PRNewswir...ay announced that 4 posters were,presented at the ...
...9, 2007 - Reata,Pharmaceuticals, Inc. today announ...ng their lead anti-cancer agent, the,Synthetic Tri...nst,common toxicities caused by traditional cancer... meeting of the Multinational,Association of Suppo...land., Reata scientists and collaborators presente...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand.
Small pupil irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip and front notch, for engaging the iris, 0.6 mm dual sideports, 20 gauge.
Irrigating nucleus chopper, 1.5 mm long wedge-shaped, inferior edge with round end, 0.6 mm dual sideports 20 gauge.
Irrigating nucleus chopper, semi-sharp, wedge shaped inferior edge with a pointed tip, dual sideports, 20 gauge. For Phakonit cataract surgery.
Medicine Products: